Click here to read the Cover Story, “Virtual reality takes next step in eye care .”In today’s world, virtual reality is universally applicable to all ages, and pediatric ophthalmology is no exception.The most traditional treatment for amblyopia is opti…
Author: Healio ophthalmology
Eligible patients may not be referred for low vision rehab
Referral for low vision rehabilitation is uneven, and clinicians may be overlooking eligible patients, according to a study published in Life.“Despite evidence supporting the effectiveness of LVR and its growing availability, utilization of LVR in the …
Virtual reality takes next step in eye care
In the last 2 years, virtual reality and augmented reality have taken a step toward more practical applications in eye care.In 2024, Healio | OSN looked at this digital technology as it was making its way into physicians’ and patients’ hands. Since the…
In 25 years as an emergency doctor, I saw patients say ‘thank you’ in these 6 ways
An elderly patient came to the ED after slipping on the ice. I knew her ankle was broken since the lower extremity was swollen and deformed.Nonetheless, she smiled, her energy was appreciative, and she thanked me each time I circled back and updated he…
3D bioprinted corneal implants may ease donor tissue shortage
In an ongoing phase 1 clinical trial, a patient who was recognized as legally blind was implanted with a 3D bioprinted corneal implant.According to a press release from Precise Bio, the implant, known as PB-001, is manufactured using a robotic 3D biofa…
FDA accepts supplemental NDA for phentolamine in presbyopia
The FDA accepted a supplemental new drug application to expand the indication for Ryzumvi to include the treatment of presbyopia, according to press releases from Opus Genetics and Viatris.“Phentolamine is designed to improve near vision by modulating …
First patient treated with quantitative cross-linking technology
The first patient has been treated in a first-in-human clinical trial investigating the safety and efficacy of the CXLens system, a quantitative corneal cross-linking, or qCXL, technology for noninvasive refractive vision correction.“This milestone rep…
Senate committee considers Casey Means, MD, for surgeon general
Lawmakers grilled Casey Means, MD, on vaccines, AI, conflicts of interest and more during Wednesday’s Senate hearing to be the next surgeon general.Means, nominated by the Trump administration, was initially set to appear before the U.S. Senate Committ…
NTX-1024 IND application for vernal keratoconjunctivitis cleared
The FDA cleared an investigational new drug application for NTX-1024 ophthalmic solution in vernal keratoconjunctivitis, paving the way for a phase 2/3 clinical trial, according to a press release from NexEos Bio.A randomized, double-masked, vehicle-co…
Pterygium excision technique does not require glue, sutures
WAIKOLOA, Hawaii — A surgical technique for pterygium excision that does not use glue or sutures yielded safety, efficacy and cost-effectiveness, according to a study published in Ophthalmology and Therapy.The retrospective analysis included 34 eyes of…
VIDEO: Innovation in retina space improves vision, anatomic outcomes
WAIKOLOA, Hawaii — In this expert perspective from Retina 2026, Sunir J. Garg, MD, FACS, FASRS, discusses how real-world data have advanced treatment of retinal vascular diseases by increasing the number of available therapy options.Garg, of Wills Eye …
Gene therapies may help patients maintain vision in AMD long term
WAIKOLOA, Hawaii — The recent progress and future development of gene therapy could help patients with wet age-related macular degeneration maintain vision, according to a speaker at Retina 2026.Allen C. Ho, MD, of Wills Eye Hospital, said gene therapy…
Ametek acquires LKC Technologies, maker of RetEval
Editor’s note: This is a developing news story. Please check back soon for updates.LKC Technologies, maker of the RetEval handheld electroretinography device, has been acquired by Ametek, according to a press release.“Becoming part of Ametek is a power…
VIDEO: Biovance 3L Ocular may work as first-line treatment for neurotrophic keratitis
WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, Marguerite B. McDonald, MD, FACS, discusses the use of DefEYE’s Biovance 3L Ocular decellularized basement membrane for the treatment of neurotrophic keratitis.“It works,” McDonald, …
Physicians only slightly more likely to die at home, in hospice
Physicians in the U.S. are only marginally more likely to die at home or in hospice than other Americans, according to study results.“There have been considerable public health efforts aimed at reducing intensive care at the end of life,” lead author V…
FDA introduces new approval process for rare disease therapies
The FDA has introduced a new approval process for targeted individualized therapies, including genome editing and RNA-based therapies, intended to treat rare and ultra rare diseases in which randomized controlled trials are not feasible.HHS Secretary R…
FDA introduces new approval process for rare disease therapies
The FDA has introduced a new approval process for targeted individualized therapies, including genome editing and RNA-based therapies, intended to treat rare and ultra rare diseases in which randomized controlled trials are not feasible.HHS Secretary R…
Tecnis Odyssey IOL encouraging in nontraditional patients
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, Carlton Yuen, MD, discusses his experience with the Tecnis Odyssey full visual range IOL.Yuen, of Aloha Vision Consultants, said the Tecnis Odyssey (Johnson & Johnson) provides…
Tecnis Odyssey IOL encouraging in nontraditional patients
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, Carlton Yuen, MD, discusses his experience with the Tecnis Odyssey full visual range IOL.Yuen, of Aloha Vision Consultants, said the Tecnis Odyssey (Johnson & Johnson) provides…
Proper technique helps mitigate surgical risks with Encelto
WAIKOLOA, Hawaii — In this Healio Video Perspective from Retina 2026, Roger A. Goldberg, MD, MBA, discusses Encelto for the treatment of macular telangiectasia type 2.Encelto (revakinagene taroretcel-lwey, Neurotech Pharmaceuticals) was approved for th…